Drug factory · FDA FEI 3011266110

Haimen Pharma Inc.

No.163, Zhuhai Rd, Binjiang Street, Haimen District, Nantong, China

China: 1

Problems found, fixed voluntarily at FDA's last inspection, Aug 25, 2023.

Voluntary Action Indicated: inspectors found problems, but not serious enough for FDA to take action. The company is expected to fix them.

2 drug inspections on record since 2020: 1 with no problems, 1 with problems fixed voluntarily, 0 with FDA action.

What it does, for whom

DrugRoleForNDC
MesalamineMakes it, tests it, packages it and labels it Lannett Company, Inc. 0527-3012
MetforminMakes it, tests it, packages it and labels it AlignScience Pharma Inc. 69948-001
ParoxetineMakes it, tests it, packages it and labels it Sinotherapeutics Inc. 69986-011, 69986-012, 69986-017
PosaconazoleMakes it, tests it, packages it and labels it Lannett Company, Inc. 0527-2133
PregabalinMakes it, tests it, packages it and labels it Sinotherapeutics Inc. 69986-013, 69986-014, 69986-015
PropafenoneMakes it, tests it, packages it and labels it Vitruvias Therapeutics, Inc. 69680-130, 69680-131, 69680-132
QuetiapineMakes it, tests it, packages it and labels it AlignScience Pharma Inc. 69948-002, 69948-003
SevelamerMakes it, tests it, packages it and labels it Insignamedex LLC, Marp Pharma 87367-266, 85898-101

FDA inspection history

EndedResultProgramProblems noted
Aug 25, 2023Problems found, fixed voluntarilyDrug Quality Assurance—
Jan 10, 2020No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture; pack.